Resources APIs-active-pharmaceutical-ingredients 
Pharmaceutical Technology
DECEMBER 16, 2022
The pharmaceutical industry must improve its environmental footprint by investing in technology and expertise, as well as through better design of new drugs early in their development, according to a GlobalData survey of the pharmaceutical industry. This is a particular problem for highly potent drugs such as antibiotics.
pharmaphorum
JULY 28, 2022
The pandemic effectively shut down supply chain paths overnight, and as a result, pharmaceutical manufacturers have faced delays and bottlenecks, which have caused drug shortages in healthcare systems. Businesses are facing challenges in obtaining raw ingredients for medicines. Logistical challenges. Building supply chain resilience.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Roots Analysis
OCTOBER 24, 2023
Owing to the advancement in clinical pharmacology and oncology domain, and the rising demand for targeted therapeutics and precision medicines, high potency active pharmaceutical ingredients (HPAPIs) and cytotoxic drugs have become one of the key areas of interest to researchers and drug manufacturers across the globe.
Pharmaceutical Technology
AUGUST 10, 2022
Companies should request evidence that the provider can deliver on time, within budget, and that they have the resources and expertise to successfully meet set project milestones.??. Any product sensitives, API configuration, time out of refrigeration (TOR) limits??? appeared first on Pharmaceutical Technology.
The Pharma Data
JUNE 7, 2022
The investment will expand the production of active pharmaceutical ingredient (API) and registered starting materials (RSMs) used in the manufacture of nirmatrelvir, a novel main protease (M pro ) inhibitor originating in Pfizer’s laboratories, which will create more than 250 additional high-skilled jobs at Pfizer’s Kalamazoo site.
Drug Discovery World
AUGUST 8, 2023
In the global pharmaceuticals market, India ranks third worldwide for production by volume and the domestic pharmaceutical market is expected to reach US$120-130 billion by 2030 1. Similarly, The Times of India says that branded generic medicines have “long fuelled India’s pharmaceutical exports” 4.
The Pharma Data
JANUARY 25, 2021
The Q-Sphera R&D pipeline has expanded to a net five active projects with all proceeding to plan. At their option, the collaboration with the European affiliate of a global pharmaceutical company has expanded to three active pharmaceutical ingredients (“API”s). Q-Sphera Pipeline.
Expert insights. Personalized for you.
162 
Let's personalize your content